Podcast: Challenges in the Development and Manufacturing of ADCs

24 Sep 2024

• By Scrip Team

Sponsored by

Explore smart strategies for overcoming ADC development and manufacturing challenges. Find your way forward in this exciting, evolving area. Listen now as experts from Olon Group share their insights with Citeline. Listen now, and explore topics including:

• How ADCs are transforming the pharma industry

• Overcoming critical technical challenges in ADC manufacturing and ADC purification across the value chain

• Leveraging Design of Experiments (DoE) advantages in the chemical development of ADCs

• Outsourcing all parts of ADC manufacturing to a single CDMO: pros and cons

• New and unique ADC capabilities at Olon

• Emerging and future challenges for ADCs

Enjoyed this podcast? find part two here.

OPPI’s Matai On Section 3(d) Of India’s Patent Regulations: Now’s The Time To Open Up

05 May 2025

• By Anju Ghangurde

Anil Matai, director general, Organization of Pharmaceutical Producers of India, talks in this audio interview about the evolving intellectual property landscape in India post the 2024 amendments, including long-standing sticking points such as Section 3(d) of India’s patent regulations and innovator firms' experience of the Bolar provision. There’s also a "compelling reason" to consider regulatory data protection, he claims.

Merck & Co. CMO Barr On Breaking Into Immunology And Ophthalmology

02 May 2025

• By Jessica Merrill

Chief medical officer Eliav Barr discussed Merck’s investment in new therapeutic areas and business development in an interview with Scrip.

Could There Be A Cure For Cardiometabolic Disease? Novo Nordisk Foundation Wants To Help Academics Find Out

01 May 2025

• By Andrew McConaghie

The not-for-profit’s senior vice president Martin Ridderstråle explains how it is expanding grants for basic research to improve "human and planetary" health.